| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,240 |
14,020 |
$791K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,091 |
15,188 |
$641K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,542 |
4,411 |
$337K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,433 |
4,184 |
$329K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,455 |
3,311 |
$262K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,471 |
3,185 |
$260K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
20,716 |
8,981 |
$241K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14,838 |
13,567 |
$202K |
| 99429 |
|
3,938 |
3,821 |
$126K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,122 |
2,007 |
$50K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,694 |
1,335 |
$36K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,915 |
3,600 |
$31K |
| 90461 |
|
6,314 |
5,117 |
$22K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
421 |
409 |
$19K |
| 99050 |
|
1,260 |
1,216 |
$18K |
| 99381 |
|
229 |
204 |
$17K |
| 90619 |
|
935 |
860 |
$14K |
| 83655 |
|
1,266 |
1,214 |
$13K |
| 90670 |
|
1,646 |
1,579 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
996 |
938 |
$9K |
| 92551 |
|
9,406 |
8,673 |
$7K |
| 96160 |
|
3,593 |
3,340 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
89 |
87 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
364 |
338 |
$5K |
| 90710 |
|
1,615 |
1,547 |
$3K |
| 90680 |
|
1,996 |
1,947 |
$3K |
| 87807 |
|
212 |
206 |
$2K |
| 99000 |
|
289 |
264 |
$2K |
| 90677 |
|
864 |
851 |
$2K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
28 |
27 |
$2K |
| 90671 |
|
592 |
577 |
$1K |
| 90651 |
|
1,278 |
1,187 |
$1K |
| 94760 |
|
12,069 |
10,602 |
$1K |
| 81002 |
|
511 |
459 |
$1K |
| 99173 |
|
9,774 |
8,952 |
$923.00 |
| 99382 |
|
43 |
41 |
$917.26 |
| 90633 |
|
1,704 |
1,643 |
$871.38 |
| 90648 |
|
1,573 |
1,530 |
$727.90 |
| 90698 |
|
324 |
317 |
$546.30 |
| 69210 |
|
16 |
13 |
$416.63 |
| 90696 |
|
645 |
625 |
$412.39 |
| 90697 |
|
860 |
845 |
$315.73 |
| 90723 |
|
783 |
760 |
$300.00 |
| 90700 |
|
658 |
640 |
$215.88 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
26 |
20 |
$207.32 |
| 85018 |
|
714 |
666 |
$204.02 |
| 90621 |
|
751 |
706 |
$127.60 |
| 90686 |
|
636 |
604 |
$98.85 |
| 97169 |
|
193 |
164 |
$61.20 |
| 90715 |
|
395 |
371 |
$45.00 |
| 36415 |
Collection of venous blood by venipuncture |
1,401 |
1,314 |
$39.30 |
| 90674 |
|
737 |
721 |
$30.01 |
| 90661 |
|
723 |
722 |
$23.33 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
13 |
13 |
$18.98 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
332 |
309 |
$13.22 |
| A7015 |
Aerosol mask, used with dme nebulizer |
12 |
12 |
$12.71 |
| 36416 |
|
1,345 |
1,269 |
$11.25 |
| 90734 |
|
223 |
211 |
$0.00 |
| 90672 |
|
150 |
143 |
$0.00 |
| 90380 |
|
37 |
33 |
$0.00 |
| 90660 |
|
37 |
37 |
$0.00 |
| 96161 |
|
21 |
21 |
$0.00 |